Matching Shaped Allocation in the CBD Social-Anxiety Trial

The CBD trial used matched patient characteristics when allocating the small treatment groups. The reported procedure is more specific than an assumption that every assignment was an unconstrained independent draw.

The methods described matching and treatment balance

The twenty-four social-anxiety patients were assigned to CBD or placebo, twelve per group. The authors described the first participant’s treatment as blindly chosen between the options, with a subsequently matched participant receiving the remaining option. Groups were matched on gender, age, education and socioeconomic status, and the patient groups were balanced on Social Phobia Inventory scores.

Balance and concealment answer different questions

Matching can reduce measured baseline differences in a small comparison. It does not guarantee balance on every unmeasured influence or replace the need for blinded treatment implementation. The description should not be expanded into an unreported allocation-concealment mechanism. Conversely, the use of matching alone is not evidence that the observed outcomes were invalid.

Keep the comparator structure visible

The randomized patient comparison addressed the acute effect of 600 mg CBD against placebo. The separate healthy group received no medication and supplied a different reference. Small samples and a single public-speaking challenge limit precision and generalization. The reported improvements in subjective outcomes should remain distinct from the null between-group physiological findings, rather than attributing every difference to the allocation procedure.

Related analysis: the public-speaking trial’s subjective and physiological findings.

Research cited

Bergamaschi and colleagues (2011). Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients. DOI: 10.1038/npp.2011.6.